Table 6.
Crude risk of CVT and other VTE related to pregnancy according antithrombotic prophylaxis.
Antithrombotic prophylaxis in women with prior CVT | VTEs (non-cerebral) |
Recurrent CVT |
||
---|---|---|---|---|
Pregnancy | Puerperium | Pregnancy | Puerperium | |
No antithrombotic prophylaxis | 2/43 47 per 1000 95% CI 13–155 | 1/57 18 per 1000 95% CI 3–93 | ||
Heparin | 0/73 0 per 1000 95% CI 0–50 | 1/76 13 per 1000 95% CI 2–71 | 0/77 0 per 1000 95% CI 0–48 | 0/89 0 per 1000 95% CI 0–41 |
Antiplatelet | 0/5 0 per 1000 95% CI 0–435 | 0/2 0 per 1000 95% CI 0–658 | 0/10 0 per 1000 95% CI 0–278 | 0/2 0 per 1000 95% CI 0–658 |
CVT: cerebral venous thrombosis; VTE: venous thromboembolism.